Ixico
The AI engine Fit Assessment
BetaIxico is a U.K.-based company specializing in clinical trial services, particularly in neuroimaging and digital biomarker solutions for neurological disorders. They provide comprehensive support for drug development analytics and have a global network of imaging centers for efficient trial execution.
Blurb
HQ Location
Founded
Employees
Total funding raised
Funding Status
- Digital Biomarkers Development
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
The IXICO Platform deploys the very latest disease-specific algorithms to create reliable clinical data and precision insights that can help accelerate R&D decision making, de-risk clinical research and maximise the potential of drug development programmes.